ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules
PRINCETON, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Duloxetine Delayed-Release Capsules 20, 30 and 60 mg. ANI’s Duloxetine Delayed-Release Capsules are the generic version of the reference listed drug (RLD) Cymbalta®.
Covered in this story
Call it yourself
No calls on $ANIP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ani Pharmaceuticals Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.